Category Archives: Psychiatry

European public-private project to advance precision psychiatry by introducing biology into clinical routine

PARIS AND MONTPELLIER, 30-Mar-2022 — /EPR HEALTHCARE NEWS/ — ALCEDIAG announces the launch of the EDIT-B Consortium, supported by the European Institute of Innovation and Technology for Health (EIT Health). This newly formed European public-private partnership aims at advancing precision psychiatry by introducing biology into clinical routine.

Around 300M people in the world are affected by depression. Studies show that up to 40% of them may be misdiagnosed and potentially bipolar. As a result, diagnosis is often delayed by an average of 7.5 years, worsening patients’ mental and physical conditions as well as their loved ones’ quality of life.

The EDIT-B Consortium aims to solve this diagnostic challenge by using specific RNA editing based biomarkers and artificial intelligence to validate and commercialize an accurate, reliable, and quick blood test to diagnose bipolar disorder.

The Consortium brings together prominent members from across Europe who will be working over the next three years to achieve this goal: Alcediag, Alcen, Capital Region of Denmark, Fundació Clinic per la Recerca Biomèdica, Fundació Sant Joan de Déu, GHU Paris Psychiatrie & Neurosciences, Hospital Clínic de Barcelona, Parc Sanitari Sant Joan de Déu, ProductLife Group and Synlab. With a total budget of € 5.2 million, EDIT-B is co-funded by the EIT Health (€ 2.5M) and the partners.

“This project will accurately separate bipolar disorder from unipolar disorder. This distinction is extremely important clinically, because the treatments are different. EDIT-B Consortium gathers all relevant expertise and as the principal investigator in the clinical trial, I hope we will be able to validate a test that will improve the lives of many people living with bipolar disorder”, says Prof. Eduard Vieta from the Hospital Clínic de Barcelona.

SYNLAB is the first diagnostic service provider in Europe, present in 36 countries in 4 continents and committed to developing high value solutions for patients  focusing on medical excellence and customer centricity.

Maurizio Ferrari, SYNLAB Italy Chief Medical Officer says: “innovation in healthcare is a key pillar for the customer centricity and  we are very proud to be part of this European research project that really may help patients with psychiatric disorders”.

“I am proud to see that the EDIT-B consortium led by our partner Alcediag – a subsidiary of Alcen – will tackle the challenge of improving the diagnosis of bipolar disorder. In doing so, they support EIT Health main mission which is to help citizens live healthier and longer lives and at the same time put the spotlight on mental health which is key to the proper care management and wellbeing of our communities”, adds Jean Marc Bourez, interim CEO of EIT Health.

“On this World Bipolar Day, Alcediag team is happy to announce its contribution to solving the bipolar disorder diagnostic issue.  We are proud and grateful to our partners and the EIT Health for this opportunity to advance science while having a positive impact on people’s lives”, said Alexandra Prieux, CEO of Alcediag.

SOURCE: EuropaWire

Kenneth Research: Increasing Concern for Mental Health Disorders to Drive Market Growth for Mental Health Software and Devices

NEW YORK, 21-Mar-2022 — /EPR HEALTHCARE NEWS/ — Every year, over 7 Million people are known to die by suicide, one of the major concerns of mental health, according to the statistics by the World Health Organization (WHO). Calculatedly, this comes to one person every 40 seconds. Moreover, in the year 2019, suicide accounted for 1.3% of the total number of deaths around the globe. On the other hand, mental health disorders, such as depression, affected 3.8% of the global population, or around 280 Million people. This included 5.0% adults and 5.7% aged adults above 60 years of age.

Kenneth Research recently released a report titled “Global Mental Health Software and Devices Market” which includes a detailed analysis of the market dynamics along with the impact of COVID-19 on the market growth during the forecast period, i.e., 2021-2030. The report also includes the regulatory and standard landscape, and in-depth research about the market growth across the five major regions, i.e., North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

In Europe, Austria (24 males, 5.6 females), Belgium (23 males, 8.6 females), France (22 males, 5.9 females), Finland (22.9 males, 7.6 females), Germany (17.3 males, 4.8 females), Sweden (17.7 males, 7.0 females), Netherlands (15.7 males, 7.0 females), has shown the highest number of death rates and self-harms per 100,000 inhabitants.

As COVID19 sweeps the global economies, Europe is one of the worst hit since 2020. As new COVID guidelines, lockdown and restriction comes into force, economies have reported elevated cases of anxiety and stress. Especially quarantine and its ill impacts have pushed levels of loneliness, depression, drug use, alcohol consumption, suicidal behavior and self-harm are pushed to another level.

Request for Research Report Sample- https://www.kennethresearch.com/report-details/mental-health-software-and-devices-market/10352350

Mental health is a major concern globally and with the rising prevalence of different types of such disorders in recent years, as well as with the growing awareness for these diseases by governmental bodies, the disease has been included in the list of 17 Sustainable Development Goals (SDGs) of the United Nations. Moreover, the situation for the disease has also gained massive focus, especially to treat the elderly population. This can be attributed primarily to the increasing elderly population count over the past few years, and the growing awareness for mental health and well-being amongst these age groups. In the other statistics by the WHO, the proportion of the population of age 60 years and over around the world is expected to double from 12% to 22% between 2015 and 2050. The statistics further stated that over 20% of these adults suffered from a mental or neurological disorder, and 6.6% of all disabilities amongst these population groups accounted for such disorders. Additionally, around 5% and 7% of these populations had been affected with dementia and depression respectively, which are the two most common mental and neurological disorders.

The global mental health software and devices market generated a revenue of USD 3883.94 Million in the year 2020 and is further expected to grow with a CAGR of 13.28% during the forecast period and touch a value of USD 13367.12 Million by the end of 2030. The growth of the market can primarily be attributed to the growing need for advanced patient monitoring and patient management applications amongst healthcare service providers for those treating mental disorders, backed by the surge in the number of mental health patients worldwide. Besides this, the increasing number of these patients is expected to drive the need for advanced devices which can help for early diagnosis and treatment, therefore contributing to the market growth in the coming years. For instance, the prevalence of dementia, which is known for deteriorating the memory, thinking, behavior, and the ability of the patients to perform everyday activities, is expected to increase to 82 Million by 2030, and further touch 152 Million by 2050, according to the statistics by the WHO. On the other hand, according to the statistics by United Nations Children’s Fund (UNICEF), in the year 2019, between the ages 10 and 14, 34,840,000 female adolescents and 44,647,000 male adolescents suffered from mental disorders. Moreover, between the ages 15 and 19, 41,712,000 female adolescents and 44,563,000 male adolescents had suffered from the same disorder. The surge in these cases is expected to boost the demand for diagnostic devices for the treatment of the disorder, and in turn, drive the market growth.

Request for Research Report Sample- https://www.kennethresearch.com/report-details/mental-health-software-and-devices-market/10352350

The growth of the global mental health software and devices market can also be attributed to the increasing number of government initiatives that focus on maintaining good mental health and well-being of the individuals of nations worldwide. For instance, in May 2013, during the 66th World Health Assembly, the Comprehensive Mental Health Action Plan 2013-2020 developed by the WHO was adopted by the Ministers of Health of the 194 Member States. This action plan was further extended until 2030 in the year 2019, during the 72nd World Health Assembly. On the other hand, according to the statistical report titled “Mental Health Atlas 2020”, published by the WHO, 75% of the Member States had a stand-alone policy or plan for mental health. This was an increase from 68% in the year 2014.

Additionally, the statistics also stated that 57% of the Member States had a stand-alone mental health law. This was an increase from 51% in the year 2014. Besides this, since 2017, 46% of the WHO Member States had updated their health policy or plan, while 27% of them had updated their law regarding mental health.

The global mental health software and devices market is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Out of the market in these regions, the market in North America generated the largest revenue of USD 1557.47 Million in the year 2020 and is further expected to touch USD 5382.17 Million by the end of 2030. One of the major factors anticipated to drive the growth of the market in the region is the increasing awareness for mental health and the rising need amongst healthcare service providers to improve their services to patients who are suffering from the disease. For instance, according to the statistics by the National Alliance on Mental Illness (NAMI), in the United States, in the year 2020, 1 in 5 U.S. adults experiences a mental illness, while 1 in 20 experienced a serious one, and 1 in 15 experienced both a substance use disorder and mental illness. In addition to this, 26.3 Million adults in the nation received virtual mental health services during the COVID-19 pandemic. Amongst those who received these services, 17.7 Million people experienced delays or cancellations in appointments, while 7.3 Million experienced delays in getting prescriptions. Moreover, 4.9 Million people were unable to access needed care. The market in the region is segmented by country into the United States and Canada. Out of the market in these countries, the market in the United States is expected to hold the largest revenue by the end of 2030 and also grow with the highest CAGR of 13.36% during the forecast period.

Request for Research Report Sample- https://www.kennethresearch.com/sample-request-10352350

On the other hand, the mental health software and devices market in Europe generated a revenue of USD 1265.71 Million in the year 2020 and is further expected to touch USD 4360.54 Million by the end of 2030, by growing with a CAGR of 13.31% during the forecast period. One of the major factors anticipated to drive the growth of the market in the region is the growing reforms in the diagnosis of mental health. For instance, on the 13th of May, 2019, the Parliamentary Assembly of the Council of Europe (PACE) on Social Affairs, Health, and Sustainable Development, had urged the member States of the Council of Europe to end coercive practices in mental health settings and further adopt a human rights-based approach which is respectful of medical ethics. The market growth in the region can also be attributed to the increasing government initiatives to improve behavioral health services and the surge in the adoption of electronic health records (EHR). The market in the region is further segmented by country into Germany, France, United Kingdom, Italy, Spain, Russia, Netherlands, and the Rest of Europe. Amongst the market in these countries, the market in France is expected to generate the largest revenue of USD 988.54 Million by the end of 2030 and further grow with a CAGR of 13.75% during the forecast period. Additionally, the market in the nation generated a revenue of USD 275.93 Million in the year 2020. Furthermore, the market in Germany registered the second-largest revenue of USD 249.35 Million in the year 2020 and is further expected to touch USD 911.35 Million by the end of 2030.

The study further incorporates Y-O-Y Growth, demand & supply and forecast future opportunity in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

The global mental health software and devices market is segmented by delivery model into subscription model and ownership model. Amongst these segments, the subscription model segment is projected to garner the largest revenue of USD 2442.34 Million by the end of 2022. Further, the segment is also expected to grow with the highest CAGR of 11.82% during the forecast period. In North America, the segment is expected to garner the highest market share by the end of 2030, while in Europe, the segment is projected to garner the largest revenue of USD 762.37 Million by the end of 2022.

The global mental health software and devices market is further segmented by end user into community clinics, hospitals, private practices, and home care settings. Among these segments, the community clinics segment registered the largest revenue of USD 1644.62 Million in the year 2020 and is further expected to touch a revenue of USD 5667.35 Million by the end of 2030. In North America, the segment generated the largest revenue of USD 660.52 Million in the year 2020 and is further projected to reach USD 2285.27 Million by the end of 2030, by growing with a CAGR of 13.35% during the forecast period. On the other hand, in the Asia Pacific, the segment is anticipated to garner the largest revenue of USD 1124.71 Million by the end of 2030, up from a revenue of USD 317.70 Million in the year 2020. Moreover, in Japan, the segment is expected to garner the largest revenue of USD 244.73 Million and further grow with a CAGR of 14.34% during the forecast period.

The global mental health software and devices market is also segmented on the basis of component, functionality, and mode of access.

Global Mental Health Software and Devices Market, Segmentation by Component

  • Software
    o Integrated Software
    o Standalone Software
  • Devices

Global Mental Health Software and Devices Market, Segmentation by Functionality

  • Clinical Functionality
    o Electronic Health Records (EHR)
    o Clinical Decision Support (CDS)
    o Care Plans/Health Management
    o E-Prescribing
    o Telehealth
  • Administrative Functionality
    o Patient/Client Scheduling
    o Document/Image Management
    o Case Management
    o Workforce Management
    o Business Intelligence
  • Financial Functionality
    o Revenue Cycle Management
    o Managed Care
    o Accounts Payable/General Ledger

Global Mental Health Software and Devices Market, Segmentation by Mode of Access

  • Desktops/Laptops
  • Tablets/Smartphone

Some of the prominent industry leaders in the global mental health software and devices market that are included in our report are Cerner Corporation, Netsmart Technologies, Inc., Qualifacts Systems, Inc., Valant, NXGN Management, LLC, Core Solutions, Inc., Holmusk USA, Inc., The Echo Group, Welligent, Inc., Credible Behavioral Health, Inc., IBM, and others.

Request for Research Report Sample- https://www.kennethresearch.com/sample-request-10352350

 

SOURCE: EuropaWire

Private Addiction Treatment in London Now Offered by a Pilot Scheme from South London and The Maudsley NHS Foundation Trusts

The Addictions Clinical Academic Group at South London and The Maudsley NHS Foundation Trust today announced a new pilot scheme offering private addiction treatment in London from their team of experts.

Nationally recognised as some of the UK’s leading addiction experts and part of the National Addiction Centre, the Maudsley team currently provide expert advice to a number of professional bodies including the GMC, the CAA, and National Air Traffic Control amongst others.

The new scheme will utilise some of their specialist addiction Consultants who will work with the private provider Clinical Partners to offer treatment to private patients in central London.

The new service will accept self-referring patients as well as referred privately funded patients from both NHS and Private Doctors and referrals from private companies. Clients are seen by the Maudsley clinicians at the Clinical Partners Wimpole Street and City consulting rooms. This is the first time that many of these distinguished clinicians have been available for patients to see privately.

The new outpatient services allow patients to continue to work while receiving the treatment they need, as well as referring those needing inpatient care to a choice of NHS and private providers. The team of Consultant Psychiatrists, Psychologists and Therapists are able to help with a wide range of addictions including alcohol, drugs, prescription medication, party drugs and sex, spending or gambling.

Mark Allen, Service Director at the Addictions Clinical Academic Group said “We’re delighted to bring some of SLAM’s expertise to this innovative new partnership between the private and public sectors.”

Barny Guthrie, CEO of Clinical Partners, said “Clinical Partners is very happy to be able to offer our clients access to some of the UK’s top addiction specialists. The Maudsley Hospital is host to a huge amount of talent and expertise and we are extremely pleased that SLAM has chosen to work with Clinical Partners.”

For further information about private addiction treatment in London or to arrange an appointment please visit http://www.clinical-partners.co.uk/how-can-we-help-you/addictions-clinic/partnership-with-maudsley-hospital

Via EPR Network
More Healthcare press releases

Brain Imaging Shows Analgesic Effect Of Meditation

Research published in the Journal of Neuroscience indicates that meditation has more potent pain-relieving effects on the brain than morphine or other pain-relieving drugs that reduce pain by 25 per cent. This study is the first to show dramatic reduction in both the brain activation related to pain, and the experience of pain itself.

“We found a big effect – about a 40 per cent reduction in pain intensity and a 57 per cent reduction in pain unpleasantness,” said lead author of the study, Fadel Zeidan, Ph D and post-doctoral research fellow at Wake Forest Medical Centre.

During the study, 15 healthy volunteers without prior experience of meditation attended four 20-minute classes on a type of meditation technique called focused attention. In this type of mindfulness, practitioners attend to their breath and release distracting emotions and thoughts.

Utilising arterial spin labelling magnetic resonance imaging (ASL MRI), the researchers examined participants’ brain activity. ASL MRI captures longer interval brain processes, including meditation, than a regular brain function MRI scan. Scans done before and after meditation training showed activity in the primary somatosensory cortex of the brain significantly dropping from very high to undetectable; this area creates the sensation of intensity and location of a painful stimulus.

The participants had pain induced in their right legs with a device that heated a tiny patch of their skin over 5 minutes to 120° F, a temperature painful to most people. Scans done on participants after meditation instruction showed decreased pain ratings in every participant, with a reduction range of 11 per cent to 93 per cent.

Interestingly, meditation caused increase in activity in the anterior insula, orbito-frontal cortex and the anterior cingulate cortex areas of the brain. Robert Coghill PhD, associate professor of neurobiology and anatomy at Wake Forest Baptist and senior author of the study said, “These areas all shape how the brain builds an experience of pain from nerve signals that are coming in from the body.”

He explained that increased activation of these areas by meditation corresponded to improved pain reduction. “One of the reasons that meditation may have been so effective in blocking pain was that it did not work at just one place in the brain, but instead reduced pain at multiple levels of processing.”

Speaking about the huge potential of meditation for use in clinical settings, Zeidan and his associates highlighted the briefness of the training needed to cause a dramatic pain-relieving effect. “This study shows that meditation produces real effects in the brain and can provide an effective way for people to substantially reduce their pain without medications,” said Zeidan.

Via EPR Network
More Healthcare press releases

Women’s Level One Weekend Mindfulness Retreat, Rome, GA: June 17-19, 2011

“It’s almost normal today to feel as if you have ADD (Attention Deficit Disorder). We’re all suffering from stimulation overload and sensory exhaustion” says Pamela Barge, MS, LPC, NCC, Director of Personal Coaching & Psychotherapy Associates, LLC dba Personal Coaching & Psychotherapy for Women. This is what led Pam to put together her special weekend mindfulness retreats which she offers to professional colleagues as sanctioned continuing education programs as well as to the general public.

“These special weekends are offered as a special time away…a time to check out from the world and into ourselves for a time”. With sunrise and candlelight yoga, tai chi, delicious plant based meals, mindful consideration of what the Buddhists call ‘Noble Silence’, opportunities to practice sitting and walking meditation as well as stimulating group discussions with like-minded folks, this may be just the ticket to slow things down and to become more connected with yourself and with life.

Pamela Barge, LPC, has a background as a marketing executive and independent entrepreneur. This business background together with her training as a therapist and her own practice of mindful meditation gives her therapy and coaching practice its unique flavor. The theoretical foundation of her work is founded upon the tenets of mindfulness and the evidence-based works of such folks as Jon Kabat Zinn, PhD, founder of the Stress Reduction Clinic at the University of Massachusetts, Thich Nhat Hanh, world renowned and revered Buddhist monk who was nominated for the Nobel Peace Prize by Martin Luther King, Sharon Salzberg of the Insight Meditation Society in Barre, Massachusetts and His Holiness the XIV Dalai Lama.

Each retreat is limited to fifteen attendees. For more information, to see an individual retreat schedule as well as her 2011 Retreat Calendar or to make a reservation, visit her website at www.womenscoaching.biz or phone Pam at 678-230-8127.

Via EPR Network
More Healthcare press releases

The National Alliance on Mental Illness Launches Social Networking Site for Young Adults

The National Alliance on Mental Illness (NAMI) has launched StrengthofUs.org, a new online community where young adults living with mental health concerns can provide mutual support in navigating unique challenges and opportunities during the critical transition years from ages 18 to 25.

The National Alliance on Mental Illness Launches Social Networking Site for Young Adults

Developed by young adults, StrengthofUs.org is a user-driven social networking community where members can connect with peers, share personal stories, creativity and helpful resources by writing and responding to blog entries, engaging in discussion groups and sharing videos, photos and other news.

The site offers resources on issues important to young adults, including:

• Healthy relationships
• Family and friends
• Campus life
• Independent living
• Finances
• Employment
• Housing
• Mental health issues

“Young adulthood is an exciting challenge, but also a confusing and stressful time for anyone,” said Michael Fitzpatrick, NAMI executive director. “Life can throw things at you fast.”

“Mental illness affects everyone. StrengthofUs.org is intended not just for young adults who have a mental illness, but for anyone entering adulthood that has a friend, parent or other family member facing a mental health problem.”

“Most of all, StrengthofUs.org is an interactive, fun space where young adults can share experiences and other information to empower each other, build relationships and offer peer support.”

StrengthofUs.org is about helping and inspiring each other,” said Alex M. White, age 23, a member of the advisory group of young adults who helped develop the Web site. “I would not be alive today if it had not been for the love, care and support I received from family, friends and loved ones.”.

About NAMI
NAMI is the nation’s largest grassroots mental health organization dedicated to improving the lives of individuals and families affected by mental illness. NAMI has over 1100 state and local affiliates that engage in research, education, support and advocacy.

Via EPR Network
More
Healthcare press releases

Top British Hypnosis & NLP Trainer Jonathan Royle Exposes The Hypnotherapy Conmen

Hypnosis is both an increasingly lucrative and rapidly expanding form of Complementary and Alternative Medicine (CAMS) and also a hugely popular form of Stage Entertainment thanks to people like Paul McKenna.

Top British Hypnosis & NLP Trainer Jonathan Royle Exposes The Hypnotherapy Conmen

But shockingly what most Hypnotherapy Practitioners won’t tell you or dare to admit is that the so called healing and therapeutic power of Hypnosis is nothing more than an elaborate Placebo Effect combined with basis suggestion and classical psychological conditioning akin to Pavlov’s Dog.

What’s even more alarming is the fact that the majority of Comedy Stage Hypnotist’s don’t even realise that whilst what they are doing works due to nothing more than Social Compliance, Basic Human Psychology and Devious Manipulation of their volunteers combined with simple suggestion and the Placebo Effect, that in actual fact what they are doing is potentially dangerous to their subjects as they are messing with people’s Belief Systems and Expectations for the entertainment of others which can have potentially very damaging side effects.

Now for the first time ever British Hypnotist Jonathan Royle has decided to lift the lid on this “Snake Oil” industry and save people potentially thousands of pounds in wasted treatment fee’s or training course payments, whilst also helping them to avoid falling prey to the rapidly growing number of badly trained, illegal, unlicensed, uninsured and potentially dangerous amateur Street Hypnotists messing with peoples mind on a street corner near you!

After years of research and real world experimentation Royle, aged 34 of Rochdale, Greater Manchester, England is so confident of his findings and conclusions on how so called Hypnosis actually works and his statement that “There’s No Such Thing As Hypnosis” that he has become the first Hypnosis Trainer to offer a 100% One Year (365 Day) Money Back Guarantee on his Home Study DVD and Multimedia Diploma Training Package.

Today Royle said “Hypnotherapist’s and Stage/Street Hypnotists who study this new package are literally Guaranteed to become Safer, more knowledgeable and more successful in their work or else I will give them their money back!”

Royle wants to stop people getting conned out of thousands of pounds for long winded Hypnotherapy and NLP Courses which brainwash them to believe in something that actually does not even exist and that’s why he has just released a Free 80 Page PDF Report entitled “The Seven Biggest Secrets of The Famous Name Millionaire NLP’ers – Life Coaches & Hypnotists” at http://www.magicalguru.com/freereport/

Royle who is one of Britain’s Leading Hypnosis Expert’s as illustrated at http://www.magicalguru.com/roylesresume/ explained that despite the fact that Hypnosis Does Not Exist and actually is nothing more than an illusion of truth combined with The Placebo effect, when this is fully understood by Alternative Practitioners and utilised to treat patients in the manner he teaches in his unique Home Study and Live Training Courses that dramatic changes can still occur!

Via EPR Network
More
Healthcare press releases

An International Panel Of Physicians Reports About A Special Way Of Healing On The Spiritual Path

An extraordinary series of lectures will be held in Fairfax, VA (near Washington, DC) and Los Angeles, CA in May, 2009. Seven Medical specialists from four countries will report about a free special way of healing for everyone. Medical doctors, veterinarians and psychologists from Europe, America, Asia, Australia and Africa have formed the Medical Scientific Group of Specialists (MWF). The task of this group, which belongs to the Bruno Groening Circle of Friends, is to record and verify healings the spiritual way. A compilation of more than 200 concise healing reports can be found on our web site: www.bruno-groening.org/english/ under the link Healings.

The international panel of physicians includes:

G. Blaettner, M.D., Germany,Board Cert. ENT
M. Galante, M.D., USA
L. Colizoli, M.D., USA, Board Cert. Psych.
K. Winchester, M.D.,USA Board Cert., Opthal.
Prof. G. Beketova, M.D., Ph.D., Ukraine, Board Cert. Pediatrics, Prof.Univ. of Kiev
R. Friewald, M.D., D.V.M., Germany
F. Gringinger, M.D., D.O., Austria, Board Cert. Family Prac.
R. Leo, USA

They will speak about their experiences on the following dates.

Saturday, May 2, 2009 at 3 – 7 pm 
(incl. 30 min. break):

George Mason University, 
Fairfax Campus
Lecture Hall, Room 1
4400 University Drive
Fairfax, VA 22030
Contact: Mrs. Heidi Gewehr at 571-313-0267 or h.gewehr@web.de
*Sunday, May 3, 2009 ~ 3 -7 pm 
(incl. 30 min. break)*:

Anderson School of Management, UCLA 
(park in structure 4)
Korn Convocation Hall – C Building 
110 Westwood Plaza
Los Angeles, CA 90095
Contact: Chris Runge at 323.394.4691 or chrismwf.info@yahoo.com

During these lectures, physicians will talk about persons who have experienced healing and freedom from long lasting, severe and chronic diseases in a miraculous way. Medical documents will be presented; the experts will explain the intricacies of a superior healing power that has been widely forgotten in modern medicine. The teachings of Bruno Groening (1906-1959), who became world famous due to extraordinary healings in the fifties, are taken as a basis for the lectures. Bruno Groening said time and again: “There is no incurable – God is the greatest physician”. He spoke about a higher power that he called the healing stream, life power or divine energy. This power is abundantly available for everyone. The knowledge about how to make use of this power is passed on free of charge in the worldwide non-profit, volunteer based organization of the Bruno Groening Circle of Friends.

The work of the MWF is supported by some well-known people in the United States, e.g. Dr. Christiane Northrup and Dr. Carl Simonton. Link to information online: http://www.bruno-groening.org/english/lectures2009.htm.

Via EPR Network
More Healthcare press releases

Wrongful Convictions Of Physicians By Department Of Health (NYSDOH) Linked To Patient Mortality

The proliferation of wrongful convictions in New York State prompted the NYS Bar Association to create a Blue Ribbon task force to study its systemic, procedural and statutory causes, and to propose solutions. Indeed, a report by the Innocence Project found New York State to be the national leader, outpacing all other states in its rate of wrongful convictions. The Blue Ribbon findings, embodied in a document entitled “ Final Report of the New York State Bar Association’s Task Force on Wrongful Convictions” was unanimously endorsed by the Association’s House of Delegates on April 4.

The findings of the Task Force provide a disturbing commentary on flagrant errors by the New York State judicial system, leading to convictions of innocent individuals. In over 50% of cases, the failures of government practices – such as misconduct by prosecutors – were to blame for the wrongful convictions.

Wrongful convictions do not solely implicate the New York State criminal justice system. They are reportedly rife in the legal practices of the NYS Department of Health (NYSDOH), known for ignoring due process and abusing power in its disciplinary actions against physicians. Several bills aiming to redress these inequities were all vetoed. Reported among many of these due process violations is the denying of witnesses for phy sicians’ defense, the use of tainted judges, and the coaching of plaintiffs by prosecutors to lie – indeed, “winning” cases is vital for their career advancement. Especially targeted in these malicious prosecutions are physicians practicing complementary medicine. One physician who wished to remain anonymous for fear of retribution remarked, “Convicting doctors is a cinch: just don’t allow them any witnesses; then the Department is free to make up whatever it wants.”

The tragedy of wrongful convictions in matters of health care affects far more than physicians. The plight of patients suddenly obliged to forgo the continuity of their medical care by the forcible removal of their long term physicians via the challenging of their license is illustrated in press and Internet releases entitled, “Patient Mortality Linked to Judicial Errors.” Noted are certain fragile patients who, “vulnerable, sick, alone, frightened and suddenly deprived of their main lifeline (their physician), became acutely demoralized, refused referrals to other doctors or failed to bond with them, eventually giving up their will to live and neglecting their medical needs.” One physician reported the untimely deaths of 7 patients, including one from suicide, the rapid decline of 8 Alzheimer’s and the relapses of 12 psychiatric patients leading to their serial hospitalizations.”

In response, petitions have now been forwarded to agencies concerned with patient20welfare, calling for independent impact studies on state-ordered patient abandonment. Agencies contacted include the U.S. Health and Human Services Administration (HHS) and the Centers for Medicare and Medicaid. The petition has also been sent to Health Commissioner Richard F. Daines, NYSDOH.

This landmark study, of major interest to medical, psychiatric and medico-legal communities and the public at large, would aim to show that abruptly severing medical and psychiatric services by state agencies has serious and sometimes fatal consequences for patients – especially patients who are disadvantaged, infirm, chronically ill or psychiatrically disabled. It would also suggest remedial action. Indeed, if state agencies assume the power of terminating the basic care to patients provided for by their physicians, they presumably also should accept the responsibility for adequately supporting said patients through crisis, by providing them with life-saving continuity of care.

Via EPR Network
More Healthcare press releases